Drug Trial Radar · NCT00002101
A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo
Last checked: Nov 19, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
450
Actual
Start
Not stated
Primary completion
Not stated
Sponsor
- Lead sponsor
- PharmaciaPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Phase 3
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 13 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To compare the efficacy of clarithromycin/ethambutol with placebo or with rifabutin at two different doses in reducing colony-forming units (CFUs) by 2 or more logarithms in patients with Mycobacterium avium Complex bacteremia and maintaining this response until 16 weeks post-randomization. To assess survival and comparative tolerability among the three treatment regimens.
Conditions
- Mycobacterium Avium-Intracellulare Infection
- HIV Infections
Interventions
Ethambutol hydrochlorideDrug
ClarithromycinDrug
RifabutinDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
44 sites in 1 country. Site status is shown where the registry gives one.
McDowell Clinic
Phoenix, Arizona
Maricopa Med Research Foundation
Phoenix, Arizona
Bay Harbor Hosp
Harbor City, California
Ctr for Special Immunology
Irvine, California
Combat Group
Los Angeles, California
Cedars Sinai Med Ctr
Los Angeles, California
Highland Gen Hosp / San Francisco Gen Hosp
Oakland, California
HIV Research Group
San Diego, California
UCSD / Ctr for Special Immunology
San Diego, California
Saint Francis Mem Hosp
San Francisco, California
San Francisco Veterans Administration Med Ctr
San Francisco, California
Sunnyvale Med Clinic
Sunnyvale, California
George Washington Univ Med Ctr
Washington D.C., District of Columbia
Veterans Administration Med Ctr
Washington D.C., District of Columbia
Infectious Disease Consultants
Altamonte Springs, Florida
TheraFirst Med Ctrs Inc
Fort Lauderdale, Florida
Dr Frank Tornaka
Fort Lauderdale, Florida
Gary Richmond MD
Fort Lauderdale, Florida
Dr Nelson Zide
Hollywood, Florida
Ctr for Special Immunology
Miami Beach, Florida
Dr Barry Rodwick
Safety Harbor, Florida
Bay Area AIDS Consortium
Tampa, Florida
Infectious Disease Research Consortium of Georgia
Atlanta, Georgia
Dr Daniel Berger
Chicago, Illinois
Univ of Kansas School of Medicine
Wichita, Kansas
Tulane Univ Med School
New Orleans, Louisiana
Dr Arnold Markowitz
Keego Harbor, Michigan
Univ of Nebraska Med Ctr / HIV Clinic
Omaha, Nebraska
East Orange Veterans Administration Med Ctr
East Orange, New Jersey
North Jersey Community Research Initiative
Newark, New Jersey
Long Island Jewish Med Ctr
New Hyde Park, New York
Chelsea Village Med Ctr / Saint Vincent's Hosp
New York, New York
Community Health Network
Rochester, New York
Nalle Clinic
Charlotte, North Carolina
Polyclinic Med Ctr
Harrisburg, Pennsylvania
Buckley Braffman Stern Med Associates
Philadelphia, Pennsylvania
Charleston Veterans Administration Med Ctr
Charleston, South Carolina
Dr Alfred F Burnside Jr
Columbia, South Carolina
Central Texas Med Foundation
Austin, Texas
Houston Veterans Administration Med Ctr
Houston, Texas
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.